Medicine & Life Sciences

1. Parkinsonian Disorders 59%
2. Synucleinopathies 56%
3. Dementia 43%
4. Cognitive Dysfunction 28%
5. Alzheimer Disease 26%
6. Population 22%
7. REM Sleep Behavior Disorder 20%
8. Amyloid 20%
9. Incidence 19%
10. Biomarkers 17%
11. Multiple System Atrophy 16%
12. Frontotemporal Dementia 15%
13. Gait 15%
14. Pathology 15%
15. Brain 14%
16. Case-Control Studies 14%
17. Movement Disorders 13%
18. Lewy Bodies 13%
19. Progressive Supranuclear Palsy 12%
20. Positron-Emission Tomography 12%
21. Constipation 12%
22. Hyperphosphatemia 11%
23. Levodopa 11%
24. Synucleins 11%
25. Islands 11%
26. Amyotrophic Lateral Sclerosis 10%
27. 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane 10%
28. Epidemiology 10%
29. Chromosomes, Human, Pair 9 10%
30. Deep Brain Stimulation 10%
31. 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 10%
32. Phenotype 10%
33. Stroke 9%
34. Cohort Studies 9%
35. Medical Record Linkage 9%
36. 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole 9%
37. Tremor 9%
38. Autopsy 9%
39. Age of Onset 8%
40. TimeLine 8%
41. Medical Records 8%
42. Mutation 8%
43. Neurodegenerative Diseases 8%
44. Secondary Parkinson Disease 8%
45. Neuroimaging 7%
46. Fluorodeoxyglucose F18 7%
47. Atrophy 7%
48. Dyskinesias 7%